Genomic analysis to identify correlates of the inflamed tumor phenotype in patients with advanced malignancies receiving immunotherapy
RNA-seq (gene expression) · human · 60 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 60 samples: 38 × YZHA vs 22 × YZGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid CellsCancer immunology research · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE285619_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1204974 and SRA study SRP554708. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 60 samples.
How we read this: 2 replicated groups read from 60 sample titles; they account for 60 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8705860 YZ-1 YZ
- GSM8705861 YZ-10 YZ
- GSM8705862 YZ-11 YZ
- GSM8705863 YZ-114 YZ
- GSM8705864 YZ-12 YZ
- GSM8705865 YZ-13 YZ
- GSM8705866 YZ-14 YZ
- GSM8705867 YZ-15 YZ
- GSM8705868 YZ-16 YZ
- GSM8705869 YZ-2 YZ
- GSM8705870 YZ-208 YZ
- GSM8705871 YZ-215 YZ
- GSM8705872 YZ-217 YZ
- GSM8705873 YZ-22 YZ
- GSM8705874 YZ-24 YZ
- GSM8705875 YZ-3 YZ
- GSM8705876 YZ-4 YZ
- GSM8705877 YZ-6 YZ
- GSM8705878 YZ-7 YZ
- GSM8705879 YZ-8 YZ
- GSM8705880 YZ-91 YZ
- GSM8705881 YZ-98 YZ
- GSM8705882 YZHA-341 YZHA
- GSM8705883 YZHA-342 YZHA
- GSM8705884 YZHA-343 YZHA
- GSM8705885 YZHA-344 YZHA
- GSM8705886 YZHA-346 YZHA
- GSM8705887 YZHA-347 YZHA
- GSM8705888 YZHA-349 YZHA
- GSM8705889 YZHA-351 YZHA
- GSM8705890 YZHA-352 YZHA
- GSM8705891 YZHA-353 YZHA
- GSM8705892 YZHA-361 YZHA
- GSM8705893 YZHA-362 YZHA
- GSM8705894 YZHA-364 YZHA
- GSM8705895 YZHA-367 YZHA
- GSM8705896 YZHA-368 YZHA
- GSM8705897 YZHA-369 YZHA
- GSM8705898 YZHA-370 YZHA
- GSM8705899 YZHA-371 YZHA
+ 20 more — browse all 60 samples with per-sample file links →
- GSE310672 Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation [RNA-seq] 48 samples shares phenotype, advanced
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares immunotherapy, advanced
- GSE315928 Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer [paired scRNA/TCR-seq] 94 samples shares immunotherapy, advanced
- GSE264741 Functional Screening and Transcriptomic Analysis Identify Novel Druggable Dependencies and Immunotherapy Targets in Desmoplastic Small Round Cell Tumor 124 samples shares immunotherapy
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples shares immunotherapy
- GSE312235 Tumors Hijack Immune-Privileging Regulons via Distinct Cell Types to Confer T Cell Desertion and Immunotherapy Resistance Across Various Cancers 72 samples shares immunotherapy
- GSE296954 Differentiation of tumor-infiltrating GZMK+ effector memory T cells associates with response to neoadjuvant immunotherapy in head and neck cancer 44 samples shares immunotherapy
- GSE242299 Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype 31 samples shares phenotype
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.